6OS0
Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 23-ID-B |
| Synchrotron site | APS |
| Beamline | 23-ID-B |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2018-06-29 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 1.033 |
| Spacegroup name | C 1 2 1 |
| Unit cell lengths | 135.530, 37.830, 111.920 |
| Unit cell angles | 90.00, 94.41, 90.00 |
Refinement procedure
| Resolution | 37.196 - 2.900 |
| R-factor | 0.2652 |
| Rwork | 0.259 |
| R-free | 0.31800 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6do1 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | PHENIX ((1.14_3260)) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 37.196 | 37.196 | 2.980 |
| High resolution limit [Å] | 2.900 | 12.970 | 2.900 |
| Rmerge | 0.276 | 0.097 | 0.806 |
| Rmeas | 0.341 | 0.125 | 1.002 |
| Total number of observations | 27811 | ||
| Number of reflections | 11842 | 142 | 858 |
| <I/σ(I)> | 2.25 | 5.13 | 0.61 |
| Completeness [%] | 91.2 | 82.1 | 93.1 |
| Redundancy | 2.349 | 2.261 | 2.373 |
| CC(1/2) | 0.926 | 0.990 | 0.354 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | LIPIDIC CUBIC PHASE | 7.6 | 293 | Protein complex was reconstituted with a 10:1 (w/w) mixture of monoolein and cholesterol. Crystals were grown in 100 mM Tris pH 7.6, 10 mM MgCl2, 25-26% PEG 300 |






